208 related articles for article (PubMed ID: 18662694)
41. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
42. Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas.
Rowand JL; Martin G; Doyle GV; Miller MC; Pierce MS; Connelly MC; Rao C; Terstappen LW
Cytometry A; 2007 Feb; 71(2):105-13. PubMed ID: 17226859
[TBL] [Abstract][Full Text] [Related]
43. On the origin of (CD105+) circulating endothelial cells.
Strijbos MH; Verhoef C; Gratama JW; Sleijfer S
Thromb Haemost; 2009 Aug; 102(2):347-51. PubMed ID: 19652886
[TBL] [Abstract][Full Text] [Related]
44. Circulating endothelial cells and endothelial progenitors as surrogate biomarkers in vascular dysfunction.
Wu H; Chen H; Hu PC
Clin Lab; 2007; 53(5-6):285-95. PubMed ID: 17605403
[TBL] [Abstract][Full Text] [Related]
45. CD146-based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells.
Widemann A; Sabatier F; Arnaud L; Bonello L; Al-Massarani G; Paganelli F; Poncelet P; Dignat-George F
J Thromb Haemost; 2008 May; 6(5):869-76. PubMed ID: 18284598
[TBL] [Abstract][Full Text] [Related]
46. Polychromatic flow cytometry identifies novel subsets of circulating cells with angiogenic potential in pediatric solid tumors.
Pradhan KR; Mund JA; Johnson C; Vik TA; Ingram DA; Case J
Cytometry B Clin Cytom; 2011 Sep; 80(5):335-8. PubMed ID: 21567939
[TBL] [Abstract][Full Text] [Related]
47. Circulating endothelial cells: a marker of vascular damage in patients with preeclampsia.
Grundmann M; Woywodt A; Kirsch T; Hollwitz B; Oehler K; Erdbruegger U; Haller H; Haubitz M
Am J Obstet Gynecol; 2008 Mar; 198(3):317.e1-5. PubMed ID: 18068139
[TBL] [Abstract][Full Text] [Related]
48. Circulating endothelial cells: a potential parameter of organ damage in sickle cell anemia?
Strijbos MH; Landburg PP; Nur E; Teerlink T; Leebeek FW; Rijneveld AW; Biemond BJ; Sleijfer S; Gratama JW; Duits AJ; Schnog JJ;
Blood Cells Mol Dis; 2009; 43(1):63-7. PubMed ID: 19356955
[TBL] [Abstract][Full Text] [Related]
49. Predictive and prognostic significance of circulating endothelial cells in advanced non-small cell lung cancer patients.
Yuan DM; Zhang Q; Lv YL; Ma XQ; Zhang Y; Liu HB; Song Y
Tumour Biol; 2015 Nov; 36(11):9031-7. PubMed ID: 26084612
[TBL] [Abstract][Full Text] [Related]
50. Identification and quantification of fetal red blood cells in maternal blood by a dual-color flow cytometric method: evaluation of the Fetal Cell Count kit.
Porra V; Bernaud J; Gueret P; Bricca P; Rigal D; Follea G; Blanchard D
Transfusion; 2007 Jul; 47(7):1281-9. PubMed ID: 17581165
[TBL] [Abstract][Full Text] [Related]
51. A new approach for rapid and reliable enumeration of circulating endothelial cells in patients.
Kraan J; Strijbos MH; Sieuwerts AM; Foekens JA; den Bakker MA; Verhoef C; Sleijfer S; Gratama JW
J Thromb Haemost; 2012 May; 10(5):931-9. PubMed ID: 22385979
[TBL] [Abstract][Full Text] [Related]
52. An internal positive control for the enumeration of CD45(+) and CD34(+) cells by flow cytometry allows monitoring of reagent and operator performance.
Guttridge MG; Belfield H; Hollyman D; Lankester A; Watt SM
Cytotherapy; 2007; 9(3):275-82. PubMed ID: 17464759
[TBL] [Abstract][Full Text] [Related]
53. An improved assay for enumeration of circulating endothelial cells.
Woywodt A; Goldberg C; Scheer J; Regelsberger H; Haller H; Haubitz M
Ann Hematol; 2004 Aug; 83(8):491-4. PubMed ID: 15168081
[TBL] [Abstract][Full Text] [Related]
54. Flow cytometric analysis of cell membrane microparticles.
Gelderman MP; Simak J
Methods Mol Biol; 2008; 484():79-93. PubMed ID: 18592174
[TBL] [Abstract][Full Text] [Related]
55. CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis.
Campioni D; Lo Monaco A; Lanza F; Moretti S; Ferrari L; Fotinidi M; La Corte R; Cuneo A; Trotta F
Haematologica; 2008 Aug; 93(8):1233-7. PubMed ID: 18556411
[TBL] [Abstract][Full Text] [Related]
56. Reproducibility of circulating endothelial cell enumeration and activation in children and adolescents.
Ryder JR; O'Connell MJ; Rudser KD; Fox CK; Solovey AN; Hebbel RP; Kelly AS
Biomark Med; 2016 May; 10(5):463-71. PubMed ID: 27071934
[TBL] [Abstract][Full Text] [Related]
57. Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma.
DuBois SG; Stempak D; Wu B; Mokhtari RB; Nayar R; Janeway KA; Goldsby R; Grier HE; Baruchel S
Pediatr Blood Cancer; 2012 Feb; 58(2):181-4. PubMed ID: 21319292
[TBL] [Abstract][Full Text] [Related]
58. The absolute counting of red cell-derived microparticles with red cell bead by flow rate based assay.
Nantakomol D; Imwong M; Soontarawirat I; Kotjanya D; Khakhai C; Ohashi J; Nuchnoi P
Cytometry B Clin Cytom; 2009 May; 76(3):191-8. PubMed ID: 18985729
[TBL] [Abstract][Full Text] [Related]
59. DRAQ5: improved flow cytometric DNA content analysis and minimal residual disease detection in childhood malignancies.
Swerts K; Van Roy N; Benoit Y; Laureys G; Philippé J
Clin Chim Acta; 2007 Apr; 379(1-2):154-7. PubMed ID: 17229416
[TBL] [Abstract][Full Text] [Related]
60. Diagnostic role of endothelial microparticles in vasculitis.
Erdbruegger U; Grossheim M; Hertel B; Wyss K; Kirsch T; Woywodt A; Haller H; Haubitz M
Rheumatology (Oxford); 2008 Dec; 47(12):1820-5. PubMed ID: 18927191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
